Deregowska Anna, Wnuk Maciej
Department of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland.
Department of Biology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland.
Cancers (Basel). 2021 Nov 27;13(23):5970. doi: 10.3390/cancers13235970.
Mammalian RAP1 (TERF2IP), the most conserved shelterin component, plays a pleiotropic role in the regulation of a variety of cellular processes, including cell metabolism, DNA damage response, and NF-κB signaling, beyond its canonical telomeric role. Moreover, it has been demonstrated to be involved in oncogenesis, progression, and chemoresistance in human cancers. Several mutations and different expression patterns of RAP1 in cancers have been reported. However, the functions and mechanisms of RAP1 in various cancers have not been extensively studied, suggesting the necessity of further investigations. In this review, we summarize the main roles of RAP1 in different mechanisms of cancer development and chemoresistance, with special emphasis on the contribution of RAP1 mutations, expression patterns, and regulation by non-coding RNA, and briefly discuss telomeric and non-telomeric functions.
哺乳动物的RAP1(TERF2IP)是最保守的端粒保护蛋白组分,除了其典型的端粒作用外,在调节多种细胞过程中发挥多效性作用,包括细胞代谢、DNA损伤反应和NF-κB信号传导。此外,它已被证明参与人类癌症的发生、发展和化疗耐药。已有报道称RAP1在癌症中有几种突变和不同的表达模式。然而,RAP1在各种癌症中的功能和机制尚未得到广泛研究,这表明有必要进一步研究。在这篇综述中,我们总结了RAP1在癌症发展和化疗耐药的不同机制中的主要作用,特别强调RAP1突变、表达模式以及非编码RNA调控的作用,并简要讨论其端粒和非端粒功能。